MUSTANG BIO, INC. (MBIO)
2025-06-30 | ||||
|---|---|---|---|---|
| General and administrative | 787 | |||
| Asset impairment | - | |||
| Research and development | 98 | |||
| Total operating expenses | 885 | |||
| Loss from operations | -885 | |||
| Interest income, net | 123 | |||
| Other income | - | |||
| Total other income | 123 | |||
| Net loss | -762 | |||
| Earnings per share, basic | -0.19 | |||
| Earnings per share, diluted | -0.19 | |||
| Weighted average number of shares outstanding, basic | 4,021,276 | |||
| Weighted average number of shares outstanding, diluted | 4,021,276 | |||